Coincidence of PTPN22 c.1858CC and FCRL3 -169CC genotypes as a biomarker of preserved residual β-cell function in children with type 1 diabetes
- 12 September 2016
- journal article
- Published by Wiley in Pediatric Diabetes
- Vol. 18 (8) , 696-705
Abstract
Genotype-phenotype studies in type 1 diabetes (T1DM) patients are needed for further development of therapy strategies. Our aims were to investigate the distribution of selected PTPN22 and FCRL3 gene polymorphisms and their associations with clinical course of disease in children with newly diagnosed T1DM from the Pomeranian region of Poland. The prospective, longitudinal study of 147 children with newly diagnosed T1DM—autoimmune subtype was conducted. The PTPN22 c.1858T>C (rs2476601) and FCRL3 -169C>T (rs7528684) polymorphisms were analyzed using polymerase chain reaction-restriction fragment length polymorphism method (PCR-RFLP) and DNA sequencing. The frequencies of genotypes were compared between the study and population-matched control group (327 random anonymous samples from the Pomeranian region). Selected patients underwent a 24-monthly follow up [periodic re-evaluation of fasting C-peptide concentration (FCP) and hemoglobin A1c (HbA1c ) level]. A significantly lower coincidence of the PTPN22 c.1858CC and FCRL3 -169CC genotypes was found in the study group compared with controls (P = 0.04). The PTPN22 c.1858CC and FCRL3 -169CC genotype combination, restricted to female patients only, was associated with well-preserved residual β-cell function throughout the entire follow up (prolonged FCP level increase up to the sixth month of disease, with further very stable dynamics—FCP median level ≥0.67 ng/mL without significant decrease up to the 24th month). HbA1c levels in this subgroup also remained the lowest during the observation period. Ascertained phenomenon could be explained by an interacting mechanism of the two polymorphisms through estrogen-regulated nuclear factor kappa B signaling in regulatory T (Treg ) lymphocytes. This hypothesis, if confirmed, may lead to further development of Treg administration-based therapies.Keywords
Funding Information
- Narodowe Centrum Nauki (N N407 184137, N N407 339239)
This publication has 36 references indexed in Scilit:
- Complex Multi-Block Analysis Identifies New Immunologic and Genetic Disease Progression Patterns Associated with the Residual β-Cell Function 1 Year after Diagnosis of Type 1 DiabetesPLOS ONE, 2013
- CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers GameThe Journal of Immunology, 2011
- Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes CasesPLOS Genetics, 2011
- The PTPN22C1858T gene variant is associated with proinsulin in new-onset type 1 diabetesBMC Medical Genetics, 2011
- Expression of the Autoimmune Susceptibility Gene FcRL3 on Human Regulatory T Cells Is Associated with Dysfunction and High Levels of Programmed Cell Death-1The Journal of Immunology, 2010
- Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T CellsThe Journal of Immunology, 2009
- Is FCRL3 a New General Autoimmunity Gene?Human Immunology, 2007
- Genetics of autoimmune diseases — disorders of immune homeostasisNature Reviews Genetics, 2006
- Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen speciesBiochemical and Biophysical Research Communications, 2005
- Diabetic ketoacidosis induces in vivo activation of human T-lymphocytesBiochemical and Biophysical Research Communications, 2004